Prognostic value of angiogenesis in solitary bone plasmacytoma

被引:72
作者
Kumar, S [1 ]
Fonseca, R [1 ]
Dispenzieri, A [1 ]
Lacy, MQ [1 ]
Lust, JA [1 ]
Wellik, L [1 ]
Witzig, TE [1 ]
Gertz, MA [1 ]
Kyle, RA [1 ]
Greipp, PR [1 ]
Rajkumar, SV [1 ]
机构
[1] Mayo Clin, Div Hematol & Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.1182/blood-2002-08-2441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiogenesis plays an important role in the biology of multiple myeloma (MM) and has prognostic importance in this disease. Solitary plasmacytoma is a localized plasma cell malignancy that progresses to MM in a significant number of patients. We examined if angiogenesis is increased in solitary plasmacytoma and if it can help identify patients likely to progress to myeloma. We studied angiogenesis in plasmacytoma biopsy samples and bone marrow biopsies from 25 patients. High-grade angiogenesis was present in 64% of plasmacytomas. In contrast, bone marrow angiogenesis was low in all patients. Patients with high-grade angiogenesis in the plasmacytome sample were more likely to progress to myeloma and had a shorter progression-free survival compared with patients with low-grade angiogenesis (P = .02). Angiogenesis is increased in solitary plasmacytoma and is a significant predictor of progression to, myeloma and provides further evidence of its importance in the pathogenesis of myeloma.
引用
收藏
页码:1715 / 1717
页数:3
相关论文
共 26 条
[1]   Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J].
Aguayo, A ;
Kantarjian, H ;
Manshouri, T ;
Gidel, C ;
Estey, E ;
Thomas, D ;
Koller, C ;
Estrov, Z ;
O'Brien, S ;
Keating, M ;
Freireich, E ;
Albitar, M .
BLOOD, 2000, 96 (06) :2240-2245
[2]  
Bellamy WT, 1999, CANCER RES, V59, P728
[3]   SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL [J].
CHAK, LY ;
COX, RS ;
BOSTWICK, DG ;
HOPPE, RT .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (11) :1811-1815
[4]   Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma [J].
Dankbar, B ;
Padró, T ;
Leo, R ;
Feldmann, B ;
Kropff, M ;
Mesters, RM ;
Serve, H ;
Berdel, WE ;
Kienast, J .
BLOOD, 2000, 95 (08) :2630-2636
[5]   CURABILITY OF SOLITARY BONE PLASMACYTOMA [J].
DIMOPOULOS, MA ;
GOLDSTEIN, J ;
FULLER, L ;
DELASALLE, K ;
ALEXANIAN, R .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :587-590
[6]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[7]   New perspectives in clinical oncology from angiogenesis research [J].
Folkman, J .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2534-2539
[8]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[9]   SOLITARY PLASMACYTOMA OF BONE - MAYO CLINIC EXPERIENCE [J].
FRASSICA, DA ;
FRASSICA, FJ ;
SCHRAY, MF ;
SIM, FH ;
KYLE, RA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (01) :43-48
[10]  
HOLLAND J, 1992, CANCER, V69, P1513, DOI 10.1002/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO